Happy to coordinate the session on metastatic breast cancer at SBOC meeting!

When you share the stage with a person you admire the most! Dr Bines it was a great honor !

Last meeting before our flight to Brazil!

Vocês estão de parabéns pela organização deste congresso de hoje do EVA - Brazilian Gynecologic Oncology Group, Daniele Assad Suzuki e dr. Eduardo Cronemberger (ao meio). 👏👏👏

Voltando para casa após dias incríveis em Chicago na Asco.

Mais um congresso com essas grandes amigas! Debora Gagliato Mayana Lopes Maíra Tavares, MD

In Seoul, with part of EVA - Brazilian Gynecologic Oncology Group

Any tips to adapt more easily to the time zone? 12 hours of difference?

Another half marathon!

Honored to be part of SBOC

Está chegando!!!!

Part of the colleagues who paticipate in this brazilian research group that studies breast cancer patients survivors

Cancer health disparities in brazilian women with breast cancer: despite having more advanced tumors, women in public institution had less access to OFS, CDK4/6 inhibitors and were treated with more aggressive surgical procedures, received more chemotherapy.

I love the opportunity to listen to these brilliant speakers! IGCS

Finishing IGCS Day2 conference with my great friend Andrea Gadelha

There’s no place like home.

Quando 3 mulheres ocupam os espaços da presidência da Sociedade Brasileira de Oncologia Clínica. Histórico! Presidente de Honra. Atual Presidente. Presidente eleita! Clarissa Baldotto Angelica Nogueira Rodrigues Anelisa Coutinho

Dica de livro e podcast para entender mais sobre equidade de gênero e tantas outras coisas. E não estou falando de feminismo…

Another great research from Brazil. 🇧🇷🌟 Daniele Assad and co-authors presented “Obesity and overweight rates in Brazilian women with non-metastatic ER+ breast cancer in adjuvant endocrine therapy”. Don’t miss it out! 👀 SABCS OncoAlert Daniele Assad Suzuki Romualdo Barroso, MD PhD

New Brazilian real-world data from GBECAM members: only 58.7% of women with nonmetastatic ER+ breast cancer adhered to adjuvant endocrine therapy. Better QoL linked to better adherence. Urgent need for survivorship support. 🔗 Full text available ascopubs.org/doi/10.1200/GO…